James S. Hanson serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, James S. Hanson has executed 15 insider transactions totaling $161.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 9, 2025 involved selling 1,677 shares valued at $17.2K.
James S. Hanson currently holds 19,092 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James S. Hanson has been a net buyer of GTHX stock. They have purchased $116.3K and sold $45.6K worth of shares.
James S. Hanson's most recent insider trade was on Sep 9, 2025, when they sold 1,677 shares at $10.23 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 12, 2024 | FTRE | $50.6K | Purchase | 2,000 | $25.30 | Discretionary |
| Jun 3, 2024 | FTRE | $0 | Option Exercise | 7,706 | $N/A | Discretionary |
| Jun 3, 2024 | FTRE | $55.4K | Payment | 2,231 | $24.85 | Discretionary |
| Jun 20, 2023 | FTRE | $0 | Other | 25 | $N/A | Discretionary |
| Jan 5, 2023 | GTHX | $3.9K | Sale | 729 | $5.41 | Discretionary |
| Jan 4, 2023 | GTHX | $9.1K | Sale | 1,639 | $5.58 | Discretionary |
| Jan 3, 2023 | GTHX | $0 | Award | 17,900 | $N/A | Discretionary |
| Jan 5, 2022 | GTHX | $15.3K | Sale | 1,445 | $10.61 | Discretionary |
| Jan 3, 2022 | GTHX | $0 | Award | 12,000 | $N/A | Discretionary |
| Jan 4, 2021 | GTHX | $0 | Award | 11,000 | $N/A | Discretionary |
| Sep 4, 2020 | GTHX | $14.9K | Purchase | 1,000 | $14.95 | Discretionary |
| Dec 26, 2018 | GTHX | $18.3K | Purchase | 1,000 | $18.25 | Discretionary |
| Dec 10, 2018 | GTHX | $32.5K | Purchase | 1,000 | $32.51 | Discretionary |